GraphTalk Pharma & Life Sciences 2025 — A Recap
Blog post from Neo4j
GraphTalk Pharma & Life Sciences 2025 focused on the application of graph technology, GraphRAG, and GenAI in the pharmaceutical and life sciences sectors, bringing together industry leaders to discuss solutions for existing data challenges. The event highlighted the use of Neo4j in various applications, such as Merck's Synaptix platform for managing R&D knowledge, Syngenta's NOCTIS toolkit for chemical reaction data, and LMU Klinikum's Project AMIGO for rare disease treatment. Bayer AG showcased its patient-centric data integration approach using graph models. The discussions emphasized the role of graph technology in enabling structured, scalable, and explainable solutions for complex biomedical data, enhancing capabilities in drug discovery, precision medicine, and more. The event underscored the growing importance of graph technology in AI-driven innovation within life sciences.